Earnings Call · Q2 FY2026·2026-08-05

Q2 26EPS -3.90%·Rev n/aQ1 26EPS -100.00%*·Rev n/aQ4 25EPS -100.00%*·Rev n/aQ3 25EPS +100.00%*·Rev n/a⚠ consensus missing

Mirum Pharmaceuticals, Inc. MIRM

Alexandra — Operator

Andrew McKibben — SVP of Strategic Finance and Investor Relations

−11.0%1d on move date3d−6.7%5d−6.4%

Research tier

Behavioral profile computed for 2 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MIRM calls or request research access.

More MIRM calls Browse calls Request research access